Peptide stability and storage: a practical primer

Stability of a peptide depends overwhelmingly on water activity. In a fully lyophilized solid (water content typically ≤5%), the molecular motion required for hydrolysis, deamidation, and oxidation is largely suppressed. In an aqueous solution, all of those reactions proceed at much higher rates.

As a rough rule, a peptide that is stable for 2 to 5 years lyophilized at −20°C is stable for 1 to 6 months as a 1 mg/mL aqueous solution at 4°C, and for 1 to 7 days at room temperature. The exact ratio depends heavily on sequence: peptides with Asn-Gly motifs (deamidation), Met or Cys (oxidation), or Asp-X motifs (aspartimide) degrade faster than sequences without those residues.

Most lyophilized peptides ship at room temperature for short transit (<5 days) without measurable degradation, then go to −20°C or −80°C for long-term storage. In practice, cold-chain failures are common and rarely visible:

• Packages held at distribution centers in summer can hit 35 to 45°C for hours.
• Receiving departments may not unpack for days.
• Lab freezers cycle through defrost or fail unnoticed.

Brief temperature excursions of a lyophilized peptide are usually inconsequential. Repeated or prolonged excursions of a reconstituted peptide are not. This is one of the practical reasons re-verification of inventory is occasionally worthwhile, particularly for materials that have been in storage for more than 12 months.

Three categories of degradation dominate during peptide storage:

• Hydrolysis — breakage of the peptide backbone, particularly at acid-labile sites (Asp-Pro is the classic) and during long aqueous storage.
• Oxidation — addition of oxygen at Met, Cys, Trp, and Tyr residues. Catalyzed by trace transition metals, accelerated by light, suppressed by inert atmosphere.
• Deamidation — conversion of Asn to Asp and Gln to Glu. The dominant solution-phase degradation pathway for many sequences. Highly sequence- and pH-dependent.

For sequences with disulfide bonds, disulfide scrambling is a fourth concern — the peptide retains its sequence but the disulfide topology changes, often with substantial impact on activity.

Repeated freeze-thaw of an aqueous peptide solution is the most common avoidable cause of degradation that we observe in re-verified inventory. Each freeze cycle concentrates the peptide at the ice interface as pure water freezes out first; the local concentration can climb 10 to 100x for a brief window. Local pH can also swing as buffer salts crystallize at different rates.

The fix is simple and is standard practice in well-run labs: reconstitute the peptide into the working buffer, aliquot into single-use volumes, freeze once, and discard each aliquot after thawing. A vial that is re-frozen 10 times and a vial that is frozen once and thawed 10 times are not the same.

Tryptophan is the most photosensitive natural amino acid — UV exposure produces oxidation products and crosslinks. Tyrosine, methionine, and cysteine are also affected. For Trp-containing peptides, amber glass or foil-wrapped vials should be used and ambient lab fluorescent light minimized during handling.

Oxygen sensitivity is reduced by lyophilizing and storing under inert atmosphere (nitrogen or argon). Vials that have been opened and re-sealed in air typically show measurable Met-sulfoxide formation within weeks even at −20°C; sealed-under-N₂ vials remain stable for years.

Pharmaceutical stability studies follow ICH Q1A(R2) and consist of two parallel arms:

• Real-time stability — the peptide is stored under intended storage conditions (e.g., 5°C or −20°C, controlled humidity) and analyzed at scheduled timepoints (0, 3, 6, 9, 12, 18, 24 months and beyond). Each timepoint pulls a sealed vial and measures HPLC purity, LC-MS identity, content, and any sequence-specific degradation markers.
• Accelerated stability — the peptide is stored at elevated temperature (typically 25°C/60% RH and 40°C/75% RH) and analyzed at 0, 1, 3, and 6 months. Accelerated data is used to model long-term behavior using Arrhenius kinetics and to support tentative shelf-life claims while real-time studies complete.

A defensible shelf life requires real-time data covering the full claim period. Accelerated data alone does not satisfy regulatory expectations for product release.

Initial release testing tells you what is in the vial today. It does not tell you what will be in the vial in 18 months, or what will be in the vial after a hot summer in shipping. For inventory held longer than 12 months, or for material with a known degradation-prone sequence, re-verification at the point of use is the only reliable way to know whether the original release values still apply.